SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!
风风
Lv4
560 积分
2023-06-06 加入
最近求助
最近应助
互助留言
Switch from adalimumab to brodalumab as a possible trigger factor for the onset of pyoderma gangrenosum
16天前
已完结
Brodalumab for the treatment of refractory Sweet syndrome
16天前
已完结
Clinical Efficacy and Safety of Interleukin-17 Inhibitors in Treating Patients with Erythrodermic Psoriasis: A Retrospective Cohort, Three-Center Study
16天前
已完结
Clinical Efficacy and Safety of Interleukin-17 Inhibitors in Treating Patients with Erythrodermic Psoriasis: A Retrospective Cohort, Three-Center Study
2个月前
已完结
Bimekizumab: dual inhibition as a promising tool in the management of hidradenitis suppurativa
2个月前
已完结
Switching to Interleukin-23 Inhibitors After Ineffectiveness of Ustekinumab: Evaluating Real-World Outcomes in Psoriasis Treatment
2个月前
已完结
Risankizumab Effectiveness and Safety in Crohn’s Disease: Real-world Data From a Large Tertiary Center
2个月前
已完结
Tislelizumab (Tevimbra) for Esophageal Cancer
2个月前
已关闭
Real-world experience of bimekizumab for adult patients with plaque psoriasis: A 16-week multicenter retrospective study
3个月前
已完结
Local injection of micro‐dose guselkumab for acrodermatitis continua of Hallopeau after failure of systemic ixekizumab treatment
4个月前
已完结
没有进行任何应助
帮大忙了
15天前
点赞,帮大忙了
16天前
点赞,速度真快
16天前
感谢,速度真快
2个月前
感谢,帮大忙了
2个月前
速度真快,感谢
2个月前
速度真快,帮大忙了
2个月前
点赞,速度真快
3个月前
感谢,帮大忙了,点赞
4个月前
点赞,帮大忙了
4个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论